Choksi Labs last traded at ₹200.90 (2026-10-13). Over the past month the stock moved +10.4%, three months the stock moved +48.8%, year the stock moved +2.8%. Its closing range over 52 weeks is ₹96.05 – ₹207.50, with the latest close 3.2% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1982, Choksi Laboratories Ltd provides contract testing and analytical services.[1]
Business Overview:[1] CLL provides contract testing and analytical services. The company analyses, for its clients, like a regulatory requirement, pharmaceuticals, food and agricultural products, construction materials, chemicals, calibration and environment monitoring services
In the latest quarter (Jun 2026), Choksi Labs reported sales of ₹12.06 crore (+7.3%) and net profit of ₹0.58 crore (+48.7%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 12.06 | 3.28 | 27.20 | 0.58 | 0.83 |
| Mar 2026 | 12.82 | 3.64 | 28.39 | 1.03 | 1.48 |
| Dec 2025 | 10.82 | 2.66 | 24.58 | 0.31 | 0.45 |
| Sep 2025 | 11.12 | 2.93 | 26.35 | 0.24 | 0.34 |
| Jun 2025 | 11.24 | 2.90 | 25.80 | 0.39 | 0.56 |
| Mar 2025 | 11.40 | 3.50 | 30.70 | 0.92 | 1.32 |
| Dec 2024 | 10.38 | 2.54 | 24.47 | 0.11 | 0.16 |
| Sep 2024 | 9.26 | 2.36 | 25.49 | 0.08 | 0.11 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +16.5% | +18.1% | +2.5% | +4.7% | +20.1% | +4.2% | +12.5% | +7.3% |
| Operating profit growth | +11.8% | +13.4% | +0.3% | +2.5% | +24.2% | +4.7% | +4.0% | +13.1% |
| Net profit growth | +700.0% | +83.3% | +35.3% | -7.1% | +200.0% | +181.8% | +12.0% | +48.7% |
| EPS growth | +1000.0% | +77.8% | +34.7% | -6.7% | +209.1% | +181.3% | +12.1% | +48.2% |
| OPM % | 25.5% | 24.5% | 30.7% | 25.8% | 26.4% | 24.6% | 28.4% | 27.2% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Choksi Labs reported sales of ₹46.01 crore (+10.1%) and net profit of ₹1.96 crore (+28.9%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 46.01 | 12.13 | 26.36 | 1.96 | 2.81 |
| Mar 2025 | 41.78 | 11.23 | 26.88 | 1.52 | 2.18 |
| Mar 2024 | 36.70 | 10.28 | 28.01 | 1.11 | 1.59 |
| Mar 2023 | 34.44 | 10.27 | 29.82 | 3.21 | 4.61 |
| Mar 2022 | 30.04 | 8.90 | 29.63 | 0.21 | 0.30 |
| Mar 2021 | 25.69 | 4.12 | 16.04 | -2.61 | -3.75 |
| Mar 2020 | 28.16 | 3.54 | 12.57 | -3.88 | -5.57 |
| Mar 2019 | 33.74 | 7.26 | 21.52 | 1.60 | 2.30 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +11.0% | -16.5% | -8.8% | +16.9% | +14.6% | +6.6% | +13.8% | +10.1% |
| Operating profit growth | +14.5% | -51.2% | +16.4% | +116.0% | +15.4% | +0.1% | +9.2% | +8.0% |
| Net profit growth | +18.5% | -342.5% | – | – | +1428.6% | -65.4% | +36.9% | +28.9% |
| EPS growth | +18.6% | -342.2% | – | – | +1436.7% | -65.5% | +37.1% | +28.9% |
| OPM % | 21.5% | 12.6% | 16.0% | 29.6% | 29.8% | 28.0% | 26.9% | 26.4% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Choksi Labs.
Get Free AI Stock Analysis FREE →No recent news available for Choksi Labs.
Choksi Labs shares were last quoted at ₹200.90 (+4.4% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Choksi Labs has a price-to-earnings (P/E) ratio of 61.24 and a price-to-book (P/B) ratio of 5.06. The industry P/E is 5.68.
The 52-week high of Choksi Labs is ₹216.95 and the 52-week low is ₹81.85.
The market capitalisation of Choksi Labs is about ₹132.24 crore.
In the latest quarter (Jun 2026), Choksi Labs reported sales of ₹12.06 crore (+7.3%) and net profit of ₹0.58 crore (+48.7%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Choksi Labs has a 3-year ROE of 6.00%, 3-year profit growth of -3.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 31.48% of Choksi Labs.
Choksi Labs belongs to the Hospital & Healthcare Services sector.
All Hospital & Healthcare Services stocks · Browse all stocks A–Z